Research Day 2019

Highlights from Research Day on March 21, 2019

A joint project of the DBEI and the Center for Clinical Epidemiology and Biostatistics at Penn.

Karen Glanz, PhD, MPH started off the day with her Featured Faculty Talk, “Food and Nutrition Environments: Is There an Elephant in the Room?” In addition to her informative talk, investigators from the UPenn PRC contributed two projects to the Poster Session. One features the message development and testing from our Skin Cancer Communication Project and the other highlights the methods and results from our core research project, The Healthy Weigh Study.

We also enjoyed the keynote with Peter Embi, MD, MS, FASP, FACMI from Indiana University School of Medicine with his personal journey through diagnosis and treatment and how the whole health system could better serve patients.

To download photos from this event, visit our Facebook album. View tweets from the event by searching #2019ResearchDay on Twitter.

Watch video and coverage of the Featured Faculty Talks here!

Article by Glanz and her team receives honor from major nutrition journal

Karen Glanz, PhD, MPH

UPenn PRC Director Karen Glanz, MPH, PhD and her co-authors received the 2019 High-Impact Award from the Journal of Nutrition Education and Behavior (JNEB) for a highly cited paper published in 2016. The publication focuses on synthesizing the evidence about how researchers measure the presence of healthful food and beverage options are in food stores – an issue of growing public interest in efforts to promote healthy eating.

Read the paper here.

 

 

Glanz K., Johnson L., Yaroch A.L., Phillips M., Ayala G.X., Davis E.L.
Measures of Retail Food Store Environments and Sales: Review and Implications for Healthy Eating Initiatives J Nutr Educ Behav 2016; 48(3)

A call for answers for the ‘Three Identical Strangers’

UPenn PRC Director, Karen Glanz, MPH, PhD and Holly Fernandez Lynch of Penn’s Department of Medical Ethics and Health Policy, shine a light on the responsibilities of the research ethics community when it comes to deceptive experiments like the 1960’s study featured in Three Identical Strangers.

Read the article here.

The opinion piece was published in Stat News, just in time for the release of the documentary on CNN and a BAFTA nomination for the filmmakers. Penn News Today featured the article in their February 11, 2019 issue here.


Nominated for Best Documentary in 2019

Year in Review – 2018

As we begin the new year 2019, we’ve compiled some highlights of the past year at the UPenn Prevention Research Center.  Enjoy the video, and note some of our key accomplishments.

  • The University of Pennsylvania made great strides towards promoting the health of students and staff, both mentally and physically. We aim to continue to contribute to these efforts!

  • The UPenn PRC Director, Karen Glanz, spent 4 months on  a sabbatical at the University of Hawaii Cancer Center, where she became an expert voice in the debate over banning sunscreens with certain ingredients, thought to cause damage to coral reefs.

  • In November,  we explored the findings of tobacco control science research with experts from Penn and around the country. We saw broad acknowledgement of the epidemic of e-cigarette use, and learned more about the devices and the marketing of these products, and the policy options being considered.

We look forward to a healthy and productive 2019 and hope to help our community continue to advance chronic disease prevention for many healthy new years ahead!

 

Karen Glanz named Associate Director and Program Leader at the Abramson Cancer Center

Monday, November 26, 2018, Abramson Cancer Center director, Robert Vonderheide and deputy director, Katherine Nathanson announced the appointment of Karen Glanz, PhD, MPH as Associate Director for Community Engaged Research and Leader for the Cancer Control Program.

“Dr. Glanz is the George A. Weiss University Professor in the Perelman School of Medicine and the School of Nursing, as one of Penn’s distinguished Penn Integrates Knowledge (PIK) Professors. Dr. Glanz is director of the federally funded UPenn Prevention Research Center. Dr. Glanz is a behavioral scientist with public health expertise. Her basic and translational research in community and healthcare settings focuses on obesity, nutrition, and the built environment; reduction of health disparities; and novel health communication technologies. She has made important and sustained contributions to cancer prevention and control.  With more than 480 publications and designation as a Most Highly-Cited Author over the past 20 years (top 0.5% of authors in the field), Dr. Glanz’s scholarship has been consistently interdisciplinary and highly influential in advancing the science of understanding, predicting, and changing health-related behavior. Dr. Glanz is an elected member of the National Academy of Medicine, served on the US Task Force on Community Preventive Services for 10 years, and is a current member of the NHLBI Advisory Council.  Dr. Glanz has been a valued member of the Cancer Control Program at the ACC since 2009.”

The Cancer Control Program is a transdisciplinary Program composed of members who focus on the identification of the genetic, behavioral, and health care determinants of cancer susceptibility and the development and implementation of strategies to lower risk and improve outcomes.

Dr. Glanz will step into the role previously held by Marilyn Schapira, MD, MPH, Principal Investigator on the UPenn PRC Economic Impact of Clinical Trials for Childhood Cancer Project. Dr. Schapira will continue to work with the Cancer Control Program at Abramson Cancer Center and teach medicine at the Perelman School of Medicine.

Highlights from the 2018 Evidence Academy

The Tobacco Control Science Evidence Academy was held last Friday, November 16, 2018 at The Study at University City. There was ample space for the 90 registrants, breakfast and lunch, along with nine different breakout sessions. All were there to learn and share research on tobacco control, cessation, and smoking technology.

View the program of the event for details and presentation titles, here.

The Plenary Addresses started us off, with Andrew Strasser, PhD, Robert Schnoll, PhD, and Andrea Villanti, PhD, MPH.

After the Clinical, Research, and Policy/Action Breakout Sessions, there was a short break to grab lunch and then take a seat for the Keynote Speaker, Kurt Ribisl, PhD, who gave his presentation on the “Demise of Cigarettes and the Rise of E-Cigarettes: Fixing our Flawed Response.”

The Planning Committee assembled a panel of specialists to discuss how tobacco is affecting Philadelphia.

Sean McCormick moderated the panel through a discussion of how they’ve been able to make changes in their organizations’ policies and provide a healthier environment. We had five Flash Talk presenters from different universities and organizations.

Support for this event was provided by the Population Science Program of Abramson Cancer Center, the Cancer Prevention and Control Research Network, and the UPenn Prevention Research Center.

  • View and download high resolution photos from our Facebook album here.
  • See what organizers, speakers and attendees had to say about the event on Twitter using #penntobaccocontrol.

 

Resources from the organizations involved in this event:

CIRNA

Penn Stop

Get Healthy Philly 

Truth Initiative

Health Promotion Council

American Cancer Society

American Lung Association

Abramson Cancer Center – Penn Medicine

How far will you go to prevent skin cancer? Penn researchers look at the options

A study was published in the American Journal of Preventive Medicine, where Penn researchers evaluate the beliefs in sun protection behaviors versus the risk of skin cancer.

It is known that practicing multiple behaviors against harmful UV rays, yet few adults report practicing more than one recommended behavior. This study examines how far a person is willing to go to prevent damage from UV rays, and which prevention measure is used most frequently.

Read the paper here

 

Bleakley A, Lazovich D, Jordan AB, Glanz K. Compensation Behaviors and Skin Cancer Prevention, American Journal of Preventive Medicine, Volume 55, Issue 6, December 2018, Pages 848-855

 

Read more about the Skin Cancer Communication Project here.

Call for Flash Talks at the Tobacco Control Conference

We are seeking researchers, graduate students, postdocs, and community public health practitioners to give 6-minute “flash talks” about tobacco research, practice, or advocacy at the Tobacco Control Science Evidence Academy on Friday, November 16, 2018 in Philadelphia. Talks in all areas of tobacco control research and practice are welcome, including:

  • New tobacco products
  • Translating research
  • Tobacco cessation programs and interventions
  • Community action
  • Tobacco use in youth
  • Retail and point of sale regulations
  • Use of technology
  • Lung cancer and screening
  • Clinical and pharmacological research
  • Health disparities
  • Health communication
  • Advocacy

To apply, please see submission details here. Submissions are due by Friday, October 26th and will be reviewed by experts from our planning committee.

The Tobacco Control Science Evidence Academy is hosted by the University of Pennsylvania sites of the Cancer Prevention and Control Research Network (CPCRN) and the Prevention Research Center (PRC). The CPCRN and the PRC are funded by the Centers for Disease Control and Prevention and the National Cancer Institute, and seek to improve health, reduce disparities, and bridge the gap between research and practice.

 

A 1-day conference on tobacco control and products in Philadelphia

This Evidence Academy will be a one-day conference designed to bring together researchers and health professionals, advocates, and policymakers, to accelerate the process of integrating research findings about tobacco prevention and control, into public health and clinical practice.

The Cancer Prevention and Control Research Network (CPCRN) and the UPenn Prevention Research Center (UPenn PRC) are funded by the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute (NCI), and seek to improve health, reduce disparities, and bridge the gap between research and practice. This event is also sponsored by the Penn Medicine Abramson Cancer Center, a world leader in cancer research, patient care, and education.

November 16, 2018
8:00 a.m. to 5:00 p.m.
The Study at University City, 3700 Walnut Street, Philadelphia, PA

Featured Speakers

• Michael Amato, PhD
Methodologist and Research Investigator
Truth Initiative

• Michael Fiore, MD, MPH, MBA
Hilldale Professor of Medicine
University of Wisconsin

• Meghan Moran, PhD
Assistant professor in Department of Health, Behavior & Society
Johns Hopkins University Bloomberg School of Public Health

• Kurt Ribisl, PhD
Professor and chair in the Department of Health Behavior
University of North Carolina Gillings School of Global Public Health

• Robert Schnoll, PhD
Associate Professor in the Department of Psychiatry
University of Pennsylvania

• Andrew Strasser, PhD
Research Associate Professor of Behavioral Health in Psychiatry
University of Pennsylvania Perelman School of Medicine

• Anil Vachani, MD
Associate Professor of Pulmonary and Critical Care Medicine
University of Pennsylvania Perelman School of Medicine

• Jennifer Irvin Vidrine, PhD
Professor in the Department of Family & Preventive Medicine
University of Oklahoma Health Sciences Center

• Andrea Villanti, PhD, MPH
Associate Professor in the Department of Psychiatry
Vermont Center on Behavior & Health at the University of Vermont

View the event program

 

Viewpoint Op Ed: Don’t let a single diagnosis define the patient

In the November 6, 2017 edition of The Philadelphia Inquirer, Karen Glanz, PhD, MPH, shares her father’s experience with health care and offers ideas on how we handle patients and their diagnosis in the future.

 

While shared and electronic medical records have many benefits, they carry unacknowledged risks. One is that the primary diagnosis becomes a patient’s identity, even when that diagnosis is in error and anxiety-provoking for the patient and family.

 

When my father was first hospitalized, he was a relatively healthy 93-year-old who could get around on his own, was mentally lucid, and could even drive. But one day he went to the emergency room weak and with jaundice. He had an obstructed biliary tract and needed a cholecystectomy, or gall bladder removal. During his treatment, the doctors examined the insides of his biliary tract using a technique called “biliary brushing” — and then informed me and my father that he had a “possible diagnosis” of pancreatic cancer.

 

The surgeon met with us and explained that at his advanced age, treatment for pancreatic cancer would be worse than the disease, and we mutually agreed that keeping a lookout for symptoms was the best approach. Dad put the cancer diagnosis out of his mind, because he had other more pressing concerns — getting back his strength, being able to eat again, and recovering from the rapid de-conditioning that occurs when a very old person is in a hospital bed for eight days.

Dad left the hospital greatly weakened and spent the next three months in a skilled nursing facility just down the hall from his apartment. I accompanied him on follow-up visits, first with the gastroenterologist. The physician assistant saw him first. When she opened up the medical record on a computer screen, she said, “I see you have pancreatic cancer.” He was taken by surprise, since he thought he was simply having a follow-up visit for the stent placed in his biliary tract. But the cancer was the headline on the medical record — the most important problem that defined him.

 

Other appointments followed, with the surgeon and oncologist. I asked them for more information about the pancreatic cancer diagnosis. What were his “numbers” or “levels” from the biliary brush cytology? Was there any staging information? As a public health professional teaching in medical and nursing schools, and conducting cancer control research, I wanted more information. I was promised specifics, but never received them, despite my persistence.

 

Dad’s next visit to the ER occurred a few months later, when he was incoherent after a fall from his bed in the skilled nursing facility. The first reaction by the ER doctors and nurses — he has pancreatic cancer. As it turned out, he had a hip fracture and internal bleeding. He was found to have a healthy enough heart to go ahead with a hip replacement, in the hope that he could walk again.

 

He never developed any symptoms of pancreatic cancer. There was one more hospitalization, nine months after the first one. He was a very weak 94-year-old and the ER doctors said, “I see he has pancreatic cancer.” This time it was pneumonia and a few days later he entered a residential hospice, where he spent his last five days receiving palliative care from a wonderful hospice team. Cause of death? Sepsis. Other significant conditions contributing to death? Probable pancreatic cancer.

 

Just a few decades ago, doctors were reluctant to tell a patient about a cancer diagnosis. Now the doctors — really, the records — couldn’t repeat the diagnosis often enough. I was troubled by the possible or probable pancreatic cancer diagnosis and how it dominated his electronic health record. And I was concerned that I never received much information to understand it. So I ordered and paid for his medical records.

 

It turns out that only the hospital records were provided; I did not receive images of his electronic health record. And it turned out that the pancreatic cancer diagnosis was cut-and-pasted from one record to the next. It was “possible biliary tract cancer or pancreatic cancer” but no definitive diagnosis was made. Apparently, though not written in the record, the imaging tests for further diagnosis were determined to be of little value, and thus were not done.

 

So was my father his pancreatic cancer? Probably not, and not even the doctors know the whole story. But it seemed like the system failed him, and me and our family. Caregivers are responsible for the accuracy of the records. Cut-and-paste doesn’t cut it. They are also responsible for putting diagnoses in appropriate clinical priority and for being sure that something does not get passed on as a dehumanizing label.

 

Sooner or later, everyone will become a patient. We need new ways to modify the medical record to preserve its link to the uniqueness of the patient, so the diagnosis doesn’t supersede the person.

 

Karen Glanz, PhD, MPH is George A. Weiss university professor of medicine and nursing at the University of Pennsylvania and director of the UPenn PRC.

 

Op ed via The Philadelphia Inquirer, Viewpoint

 

PRC Director, Karen Glanz Appointed to The Editorial Board: American Journal of Preventive Medicine

Karen Glanz, PhD, MPH, was recently appointed to the Editorial Board for the American Journal of Preventive Medicine. “Members of the AJPM editorial board perform myriad services for the journal including peer reviewing, recommending reviewers in their areas of expertise, serving as guest editors for supplements and themes, and acting as ambassadors for the journal. Our editorial board members are key to helping AJPM stay at the forefront of preventive medicine and public health.”

 

Read more from the AJPM in their recent newletter here.

Community Scholars In-Residence 2017-2018

Congratulations to our Community Scholars In-Residence for 2017-2018

Akin Oyalowo, M.D.

Joseph Benci Ph.D., MPH

Yujue Wang, M.D., Ph.D.

 

Through this program—

  • Scholars develop relationships with a community research partner of their choosing, identify research opportunities, and co-develop research projects during a one year tenure
  • Project topics fall under a broad spectrum of cancer prevention and control topics including primary prevention, access to care, minority populations, and epidemiology
  • Standing pre/post docs with an interest in conducting community-engaged health research are eligible for this program

 

We look forward to working with our next cohort of scholars as they increase their research capacity by developing relationships with community partners, establishing best practices in community-engaged research, and leveraging activities for scholarship and improved health outcomes!